Two Studies Support Benefit Of Investigational Drug For Nonproliferative Diabetic Retinopathy | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Thursday, December 15, 2011

Ocular Surgery News

Data from two phase 3 clinical trials offered evidence that ruboxistaurin may benefit patients with nonproliferative diabetic retinopathy.

Which of the following helps to differentiate between orbital infection and inflammation?
1. proptosis
2. pain with eye movements
3. presence of sinus disease
4. sudden onset
5. erythema
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us